These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 8887591)

  • 21. Characterization of heparan sulfate on hepatocytes in regenerating rat liver.
    Kimura A; Toyoki Y; Hakamada K; Yoshihara S; Sasaki M
    J Hepatobiliary Pancreat Surg; 2008; 15(6):608-14. PubMed ID: 18987931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant heparan sulfate profile in the human diabetic kidney offers new clues for therapeutic glycomimetics.
    Wijnhoven TJ; Lensen JF; Rops AL; van der Vlag J; Kolset SO; Bangstad HJ; Pfeffer P; van den Hoven MJ; Berden JH; van den Heuvel LP; van Kuppevelt TH
    Am J Kidney Dis; 2006 Aug; 48(2):250-61. PubMed ID: 16860191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive diagnosis of tubular damage by the use of the urinary chondroitin-4-sulfate/heparan sulfate ratio.
    Lubec G; Kircher S; Grillenberger A
    Padiatr Padol; 1986; 21(4):357-61. PubMed ID: 2951642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in heparan sulfate are associated with delayed wound repair, altered cell migration, adhesion and contractility in the galactosyltransferase I (beta4GalT-7) deficient form of Ehlers-Danlos syndrome.
    Götte M; Spillmann D; Yip GW; Versteeg E; Echtermeyer FG; van Kuppevelt TH; Kiesel L
    Hum Mol Genet; 2008 Apr; 17(7):996-1009. PubMed ID: 18158310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminura.
    McAuliffe AV; Fisher EJ; McLennan SV; Yue DK; Turtle JR
    Diabet Med; 1996 Aug; 13(8):758-63. PubMed ID: 8862953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased serum transforming growth factor-β1 concentration with aging is associated with the severity of emphysema in chronic obstructive pulmonary disease.
    Kamio K; Ishii T; Motegi T; Hattori K; Kusunoki Y; Azuma A; Gemma A; Kida K
    Geriatr Gerontol Int; 2013 Oct; 13(4):1069-75. PubMed ID: 23441714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating glycosaminoglycan species in septic shock.
    Nelson A; Berkestedt I; Bodelsson M
    Acta Anaesthesiol Scand; 2014 Jan; 58(1):36-43. PubMed ID: 24341693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary heparan sulphate is increased in normoalbuminuric diabetic patients.
    Elbert AE; Paglione AM; Bragagnolo JC; Mainetti HA; Bonavita CD; Ruiz M
    Medicina (B Aires); 2000; 60(2):195-201. PubMed ID: 10962808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulfation of heparan sulfate associated with amyloid-beta plaques in patients with Alzheimer's disease.
    Bruinsma IB; te Riet L; Gevers T; ten Dam GB; van Kuppevelt TH; David G; Küsters B; de Waal RM; Verbeek MM
    Acta Neuropathol; 2010 Feb; 119(2):211-20. PubMed ID: 19636575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.
    Praticò D; Basili S; Vieri M; Cordova C; Violi F; Fitzgerald GA
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1709-14. PubMed ID: 9847257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variable expression of heparan sulfate epitopes in crescents of human glomerulonephritis.
    Morita H; Shinzato T; Isobe KI; Kitani K; Kimata K; Maeda K
    Virchows Arch; 1999 Feb; 434(2):145-51. PubMed ID: 10071249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of flow cytometry for characterization and fractionation of cell populations based on their expression of heparan sulfate epitopes.
    Holley RJ; Smith RA; van de Westerlo EM; Pickford CE; Merry CL; van Kuppevelt TH
    Methods Mol Biol; 2015; 1229():239-51. PubMed ID: 25325958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling.
    Gulati K; Poluri KM
    Glycoconj J; 2016 Feb; 33(1):1-17. PubMed ID: 26635091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Designing CXCL8-based decoy proteins with strong anti-inflammatory activity in vivo.
    Falsone A; Wabitsch V; Geretti E; Potzinger H; Gerlza T; Robinson J; Adage T; Teixeira MM; Kungl AJ
    Biosci Rep; 2013 Sep; 33(5):. PubMed ID: 23919527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency.
    Stolk J; Veldhuisen B; Annovazzi L; Zanone C; Versteeg EM; van Kuppevelt TH; Berden JH; Nieuwenhuizen W; Iadarola P; Luisetti M
    Respir Res; 2005 May; 6(1):47. PubMed ID: 15927063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered composition of urinary heparan sulfate in patients with COPD.
    van de Lest CH; Versteeg EM; Veerkamp JH; Berden JH; van den Born J; Heunks L; Lammers JW; van Herwaarden CL; Dekhuijzen PN; van Kuppevelt TH
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):952-8. PubMed ID: 8887591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum and urinary concentrations of heparan sulfate in patients with diabetic nephropathy.
    Yokoyama H; Sato K; Okudaira M; Morita C; Takahashi C; Suzuki D; Sakai H; Iwamoto Y
    Kidney Int; 1999 Aug; 56(2):650-8. PubMed ID: 10432405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urine glycosaminoglycans and heparan sulfate excretions in adult patients with glomerular diseases.
    Mitsuhashi H; Tsukada Y; Ono K; Yano S; Naruse T
    Clin Nephrol; 1993 May; 39(5):231-8. PubMed ID: 8513598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diaphragm dysfunction in chronic obstructive pulmonary disease: a role for heparan sulphate?
    Ottenheijm CA; Jenniskens GJ; Geraedts MC; Hafmans T; Heunks LM; van Kuppevelt TH; Dekhuijzen PN
    Eur Respir J; 2007 Jul; 30(1):80-9. PubMed ID: 17392321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A syngeneic monoclonal antibody to murine Meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG): cell density and transformation dependent alteration in cell surface HS-GAG defined by HepSS-1.
    Kure S; Yoshie O
    J Immunol; 1986 Dec; 137(12):3900-8. PubMed ID: 2431047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.